{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:38:44Z","timestamp":1791290324883,"version":"4.3.0"},"reference-count":30,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:sec>\n                    <jats:title>Object<\/jats:title>\n                    <jats:p>Laser interstitial thermal therapy has been used as an ablative treatment for glioma; however, its development was limited due to technical issues. The NeuroBlate System incorporates several technological advances to overcome these drawbacks. The authors report a Phase I, thermal dose\u2013escalation trial assessing the safety and efficacy of NeuroBlate in recurrent glioblastoma multiforme (rGBM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with suspected supratentorial rGBM of 15- to 40-mm dimension and a Karnofsky Performance Status score of \u2265 60 were eligible. After confirmatory biopsy, treatment was delivered using a rigid, gas-cooled, side-firing laser probe. Treatment was monitored using real-time MRI thermometry, and proprietary software providing predictive thermal damage feedback was used by the surgeon, along with control of probe rotation and depth, to tailor tissue coagulation. An external data safety monitoring board determined if toxicity at lower levels justified dose escalation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ten patients were treated at the Case Comprehensive Cancer Center (Cleveland Clinic and University Hospitals\u2013Case Medical Center). Their average age was 55 years (range 34\u201369 years) and the median preoperative Karnofsky Performance Status score was 80 (range 70\u201390). The mean tumor volume was 6.8 \u00b1 5 cm\n                      <jats:sup>3<\/jats:sup>\n                      (range 2.6\u201319 cm\n                      <jats:sup>3<\/jats:sup>\n                      ), the percentage of tumor treated was 78% \u00b1 12% (range 57%\u201390%), and the conformality index was 1.21 \u00b1 0.33 (range 1.00\u20132.04). Treatment-related necrosis was evident on MRI studies at 24 and 48 hours. The median survival was 316 days (range 62\u2013767 days). Three patients improved neurologically, 6 remained stable, and 1 worsened. Steroid-responsive treatment-related edema occurred in all patients but one. Three had Grade 3 adverse events at the highest dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      NeuroBlate represents new technology for delivering laser interstitial thermal therapy, allowing controlled thermal ablation of deep hemispheric rGBM. Clinical trial registration no.: NCT00747253 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"ClinicalTrials.gov\" ext-link-type=\"uri\" xlink:type=\"simple\">ClinicalTrials.gov<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2013.1.jns1291","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T12:13:04Z","timestamp":1365163984000},"page":"1202-1219","source":"Crossref","is-referenced-by-count":207,"title":["Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma"],"prefix":"10.3171","volume":"118","author":[{"given":"Andrew E.","family":"Sloan","sequence":"first","affiliation":[{"name":"Brain Tumor & Neuro-Oncology Center and Department of Neurosurgery, and"},{"name":"Case Comprehensive Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet S.","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"},{"name":"Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Valerio-Pascua","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"},{"name":"Department of Neurosurgery, Cleveland Clinic;"},{"name":"Department of Neurosurgery, Cleveland Clinic Florida, Weston, Florida; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Manjila","sequence":"additional","affiliation":[{"name":"Brain Tumor & Neuro-Oncology Center and Department of Neurosurgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Torchia","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Jones","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"},{"name":"Department of Neuroradiology, Radiology Institute, Cleveland Clinic, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Sunshine","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, and"},{"name":"Department of Radiology, University Hospitals Case Medical Center, Seidman Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Phillips","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"},{"name":"Department of Neuroradiology, Radiology Institute, Cleveland Clinic, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Griswold","sequence":"additional","affiliation":[{"name":"Brain Tumor & Neuro-Oncology Center and Department of Neurosurgery, and"},{"name":"Department of Biomedical Engineering, Case Western Reserve University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clampitt","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospitals Case Medical Center, Seidman Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Brewer","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jochum","sequence":"additional","affiliation":[{"name":"Brain Tumor & Neuro-Oncology Center and Department of Neurosurgery, and"},{"name":"Case Comprehensive Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"McGraw","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Diorio","sequence":"additional","affiliation":[{"name":"Brain Tumor & Neuro-Oncology Center and Department of Neurosurgery, and"},{"name":"Case Comprehensive Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Ditz","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, and"},{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic;"},{"name":"Department of Neurosurgery, Cleveland Clinic;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns1291","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00006123-199804000-00013","article-title":"Survival and functional status after resection of recurrent glioblastoma multiforme","volume":"42","author":"Barker","year":"1998"},{"key":"b2-jns1291","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11060-006-9295-x","article-title":"Gliosarcoma with multiple extracranial metastases: case report and review of the literature","volume":"83","author":"Beaumont","year":"2007"},{"issue":"1 Suppl 1","key":"b3-jns1291","series-title":"Neurosurgery","first-page":"ONS21","article-title":"Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors","volume":"63","author":"Carpentier","year":"2008"},{"key":"b4-jns1291","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ijrobp.2007.03.061","article-title":"Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme","volume":"69","author":"Chen","year":"2007"},{"key":"b5-jns1291","series-title":"Stat Med","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/sim.1336","article-title":"Improved up-and-down designs for phase I trials","volume":"22","author":"Ivanova","year":"2003"},{"key":"b6-jns1291","series-title":"J Comput Assist Tomogr","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00004728-199407000-00002","article-title":"MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms","volume":"18","author":"Kahn","year":"1994"},{"key":"b7-jns1291","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jmri.1880080128","article-title":"In vivo MRI thermometry using a phase-sensitive sequence: preliminary experience during MRI-guided laser-induced interstitial thermotherapy of brain tumors","volume":"8","author":"Kahn","year":"1998"},{"key":"b8-jns1291","series-title":"Lasers Surg Med","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/lsm.20069","article-title":"Thermal therapy of canine cerebral tumors using a 980 nm diode laser with MR temperature-sensitive imaging feedback","volume":"35","author":"Kangasniemi","year":"2004"},{"key":"b9-jns1291","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00312543","article-title":"Thrombosis and intracranial tumors","volume":"209","author":"Kayser-Gatchalian","year":"1975"},{"key":"b10-jns1291","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00006123-199710000-00004","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997"},{"key":"b11-jns1291","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001"},{"key":"b12-jns1291","series-title":"Minim Invasive Neurosurg","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2002-36203","article-title":"Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical experience","volume":"45","author":"Leonardi","year":"2002"},{"key":"b13-jns1291","series-title":"Minim Invasive Neurosurg","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-2001-13581","article-title":"Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR-unit","volume":"44","author":"Leonardi","year":"2001"},{"key":"b14-jns1291","series-title":"Am J Dermatopathol","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/DAD.0b013e31817532c4","article-title":"Glioblastoma multiforme in skin: a report of 2 cases and review of the literature","volume":"30","author":"Mentrikoski","year":"2008"},{"key":"b15-jns1291","series-title":"Cent Eur Neurosurg","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-2008-1080941","article-title":"Multifocal glioblastoma with remote cutaneous metastasis: a case report and review of the literature","volume":"70","author":"Miliaras","year":"2009"},{"key":"b16-jns1291","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Central Nervous System Cancers, Version 1.2013","author":"National Comprehensive Cancer Network","year":"2012"},{"key":"b17-jns1291","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jmri.1880080140","article-title":"MR-monitored LITT as a palliative concept in patients with high grade gliomas: preliminary clinical experience","volume":"8","author":"Reimer","year":"1998"},{"issue":"6","key":"b18-jns1291","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2009.9.FOCUS09187","article-title":"Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme","volume":"27","author":"Romanelli","year":"2009"},{"key":"b19-jns1291","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas. Clinical article","volume":"115","author":"Sanai","year":"2011"},{"key":"b20-jns1291","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0360-3016(84)90379-1","article-title":"Thermal dose determination in cancer therapy","volume":"10","author":"Sapareto","year":"1984"},{"key":"b21-jns1291","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/00006123-199805000-00054","article-title":"Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors","volume":"42","author":"Sawaya","year":"1998"},{"key":"b22-jns1291","series-title":"Eur J Radiol","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejrad.2006.05.010","article-title":"MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients","volume":"59","author":"Schwarzmaier","year":"2006"},{"key":"b23-jns1291","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/jmri.20446","article-title":"MR-guided laser irradiation of recurrent glioblastomas","volume":"22","author":"Schwarzmaier","year":"2005"},{"key":"b24-jns1291","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/jmri.1880080124","article-title":"Treatment planning for MRI-guided laser-induced interstitial thermotherapy of brain tumors\u2014the role of blood perfusion","volume":"8","author":"Schwarzmaier","year":"1998"},{"key":"b25-jns1291","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00006123-200208000-00009","article-title":"The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine","volume":"51","author":"Selker","year":"2002"},{"key":"b26-jns1291","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000"},{"key":"b27-jns1291","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0360-3016(97)00731-1","article-title":"Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +\/\u2212 hyperthermia for glioblastoma multiforme","volume":"40","author":"Sneed","year":"1998"},{"key":"b28-jns1291","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004"},{"key":"b29-jns1291","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005"},{"key":"b30-jns1291","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1227\/01.NEU.0000170560.13251.99","article-title":"Radiosurgery in the treatment of malignant gliomas: the University of Florida experience","volume":"57","author":"Ulm","year":"2005"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/118\/6\/article-p1202.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/118\/6\/article-p1202.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/118\/6\/article-p1202.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:51:02Z","timestamp":1660485062000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/118\/6\/article-p1202.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":30,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2013.1.jns1291","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}